Last reviewed · How we verify
PrimeC
PrimeC is a nutritional supplement formulation designed to support immune and antioxidant function through a combination of vitamins and micronutrients.
PrimeC is a nutritional supplement formulation designed to support immune and antioxidant function through a combination of vitamins and micronutrients. Used for Immune support and antioxidant supplementation.
At a glance
| Generic name | PrimeC |
|---|---|
| Sponsor | NeuroSense Therapeutics Ltd. |
| Modality | Small molecule |
| Therapeutic area | Nutritional supplement / Immune support |
| Phase | FDA-approved |
Mechanism of action
PrimeC contains vitamin C and other micronutrients intended to enhance immune response and provide antioxidant protection. The formulation is marketed as a supportive nutritional product rather than a pharmaceutical drug with a specific molecular mechanism of action.
Approved indications
- Immune support and antioxidant supplementation
Common side effects
Key clinical trials
- A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS (PHASE2)
- A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease. (PHASE2)
- A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablets Co-administered With Celecoxib Capsules, in Healthy Adult Subject (PHASE1)
- A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects (PHASE1)
- Ciprofloxacin/Celecoxib Combination in Patients With ALS (PHASE1)
- Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |